LACRIFAST LF2-R090

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2017-06-15 for LACRIFAST LF2-R090 manufactured by Kaneka Corporation.

Event Text Entries

[77840359] - the concerned device "lacrifast" is not distributed in us under this device name, but is identical to the device "lacriflow lacrimal stent" distributed in us under 510(k) # k120886. - we originally found this information on 5/25/2017 in a preliminary program of (b)(6), scheduled in this july, by a title of presentation. We made an interview to the author of the presentation on 6/7/2017 to confirm the event subject to the presentation more in detail. According to the dr. Interviewed, the event occurred about one year before (in 2016) and the physician, who performed the actual procedure, was moved out of this facility. The dr. Interviewed provided us with the available information of the case described in this report. - the expiry of the device is for 3 years. As the lot no. Of the concerned device was not available, the device history records (dhr) of the devices manufactured since its first production in 2015 till the end of 2016, where the device concerned should be included, and confirmed that the device met its material, assembling and product specifications. - the physician in charge commented that this problem was not due to any device failure but to their procedural problem by making a false passage and not being able to retrieve the device appropriately. - we speculated the cause of torn off the tip of the tube and remained in the patient as follows: as described above in "describe event or problem", the tube insertion by using the bougie created a false passage in the occluded nasal duct. The tip portion was stuck tightly in the false passage, and was torn off by an excessive tensile force while the physician forcibly pulled the tube out of the patent. We determine, as commented by the physician in charge, the problem was caused not by any defect of the device but by the handling issue of the user.
Patient Sequence No: 1, Text Type: N, H10


[77840360] This device (lacrifast) was employed to treat the epiphora due to nasal duct blockage of a pediatric female patient. While inserting this lacrimal duct tube into the nasal duct, the physician realized that a false passage was created. The physician tried to remove the tube but the tube could not be pulled back. Accordingly, the physician made an incision of the lacrimal sac and pulled back the tube, and then, the tip of the tube was torn off and remained in the patient, since the tip of the tube was entered deep into and stuck in the tissues. The physician gave up to remove the remained tip portion out of the patient, and placed a new lacrimal duct tube in the nasal duct successfully to complete the operation.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9614654-2017-00007
MDR Report Key6645805
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2017-06-15
Date of Report2017-05-25
Date Mfgr Received2017-05-25
Date Added to Maude2017-06-15
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. KAZUHIKO INOUE
Manufacturer Street2-3-18 NAKANOSHIMA,KITA-KU
Manufacturer CityOSAKA, OSAKA 530-8288
Manufacturer CountryJA
Manufacturer Postal530-8288
Manufacturer Phone31814120
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLACRIFAST
Generic NameLACRIMAL STENT
Product CodeOKS
Date Received2017-06-15
Catalog NumberLF2-R090
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerKANEKA CORPORATION
Manufacturer Address2-3-18 NAKANOSHIMA, KITA-KU OSAKA, OSAKA 530-8288 JA 530-8288


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2017-06-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.